| Chitosan/PVA hydrogels incorporated with green synthesized cerium oxide nanoparticles for wound healing applications K Kalantari, E Mostafavi, B Saleh, P Soltantabar, TJ Webster European Polymer Journal 134, 109853, 2020 | 174 | 2020 |
| Nanotechnology and picotechnology: a new arena for translational medicine E Mostafavi, P Soltantabar, TJ Webster Biomaterials in translational medicine, 191-212, 2019 | 91 | 2019 |
| Electroconductive nanobiomaterials for tissue engineering and regenerative medicine E Mostafavi, D Medina-Cruz, K Kalantari, A Taymoori, P Soltantabar, ... Bioelectricity 2 (2), 120-149, 2020 | 66 | 2020 |
| Enhancement of loading efficiency by coloading of doxorubicin and quercetin in thermoresponsive polymeric micelles P Soltantabar, EL Calubaquib, E Mostafavi, MC Biewer, MC Stefan Biomacromolecules 21 (4), 1427-1436, 2020 | 57 | 2020 |
| Heart/liver-on-a-chip as a model for the evaluation of cardiotoxicity induced by chemotherapies P Soltantabar, EL Calubaquib, E Mostafavi, A Ghazavi, MC Stefan Organs-on-a-Chip 3, 100008, 2021 | 16 | 2021 |
| Self-assembly behavior of oligo (ethylene glycol) substituted polycaprolactone homopolymers EL Calubaquib, P Soltantabar, H Wang, H Shin, A Flores, MC Biewer, ... Polymer Chemistry 12 (24), 3544-3550, 2021 | 11 | 2021 |
| Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road ahead P Soltantabar, HK Lon, K Parivar, DD Wang, M Elmeliegy Critical Reviews in Oncology/Hematology 182, 103913, 2023 | 7 | 2023 |
| Dose optimization to mitigate the risk of CRS with elranatamab in multiple myeloma M Elmeliegy, A Viqueira, E Vandendries, A Hickman, J Hibma, HK Lon, ... Blood 140 (Supplement 1), 7174-7175, 2022 | 6 | 2022 |
| Diketopyrrolopyrrole and benzodithiophene based near infrared-emitting small molecule for imaging applications KE Washington, J Du, RN Kularatne, EL Calubaquib, P Soltantabar, ... Synthetic Metals 256, 116123, 2019 | 6 | 2019 |
| A systematic meta-analysis of cytokine release syndrome incidence in B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy and bispecific antibodies for … S Sharma, D Wang, HK Lon, P Soltantabar, A Viqueira, A Czibere, ... Blood 140 (Supplement 1), 10036-10038, 2022 | 5 | 2022 |
| Biodegradable Aliphatic Polyesters for Drug Delivery V Karmegam, P Soltantabar, EJL Calubaquib, RN Kularatne, MC Stefan Material Matters 12, 37-41, 2017 | 4 | 2017 |
| Case–control matching‐guided exposure‐efficacy relationship for avelumab in patients with urothelial carcinoma P Soltantabar, A Alhadab, J Hibma, S Roychoudhury, DD Wang, C Bello, ... CPT: Pharmacometrics & Systems Pharmacology 12 (12), 2001-2012, 2023 | 1 | 2023 |
| Impact of Treatment Modality and Route of Administration on Cytokine Release Syndrome in Relapsed or Refractory Multiple Myeloma: A Meta‐Analysis P Soltantabar, S Sharma, D Wang, HK Lon, A Czibere, A Hickmann, ... Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| P-315 Elranatamab exposure-safety analysis in patients with relapsed/refractory multiple myeloma: analysis from MagnetisMM studies P Soltantabar, D Irby, J Hibma, D Wang, J Williams, A Czibere, A Viqueira, ... Clinical Lymphoma Myeloma and Leukemia 23, S211-S212, 2023 | | 2023 |
| Organ Chips in Safety Pharmacology MC Stefan, P Soltantabar, H Wang, A Bhadran, H Polara, T Shah Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, 1-21, 2023 | | 2023 |
| Optimizing benefit/risk in oncology: Review of post marketing dose optimization P Soltantabar, HK Lon, K Parivar, D Wang, M Elmeliegy Cancer Research 83 (7_Supplement), 5063-5063, 2023 | | 2023 |
| Microfabrication of an Organ-on-a-chip Device to Model Cardiotoxicity Induced by Chemotherapies for Cancer Nanomedicine Evaluation P Soltantabar The University of Texas at Dallas, 2020 | | 2020 |
| Organs-on-a-Chip P Soltantabar, EL Calubaquib, E Mostafavi, A Ghazavi, MC Stefan | | |
Ebrahim Mostafavi, PhDStanford UniversityVerified email at stanford.edu
